XCUR
Exicure IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$17.72M
P/E Ratio
—
EPS
$-1.57
Beta
3.54
52W High
$9.50
52W Low
$2.62
50-Day MA
$3.33
200-Day MA
$4.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Exicure Inc
Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-3.29M |
| EBITDA | $-8.46M |
| Operating Margin | 0.00% |
| Return on Equity | -145.20% |
| Return on Assets | -32.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.62 |
| Price-to-Book | 8.23 |
| Price-to-Sales (TTM) | 13.61 |
| EV/Revenue | 27.17 |
| EV/EBITDA | -0.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 928.00% |
| Shares Outstanding | $6.37M |
| Float | $3.38M |
| % Insiders | 35.38% |
| % Institutions | 2.69% |
Historical Volatility
HV 10-Day
62.38%
HV 20-Day
87.47%
HV 30-Day
74.51%
HV 60-Day
65.59%
HV Rank
30.2%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026